IIM
DFTX

INTECH Investment Management’s Definium Therapeutics DFTX Stock Holding History

INTECH Investment Management’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$472K Sell
24,990
-4,665
-16% -$79.2K ﹤0.01% 1355
2025
Q4 		$397K Buy
29,655
+2,521
+9% +$31.2K ﹤0.01% 1616
2025
Q3 		$320K Sell
27,134
-10,552
-28% -$98.4K ﹤0.01% 1794
2025
Q2 		$245K Sell
37,686
-17,304
-31% -$114K ﹤0.01% 1989
2025
Q1 		$322K Buy
54,990
+25,428
+86% +$182K ﹤0.01% 1850
2024
Q4 		$206K Buy
29,562
+6,089
+26% +$41.9K ﹤0.01% 2019
2024
Q3 		$134K Buy
+23,473
New +$163K ﹤0.01% 1830

Other funds holding DFTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

INTECH Investment Management's DFTX Position: Q1 2026 in Review

INTECH Investment Management reduced its Definium Therapeutics (DFTX) stake by 16% in Q1 2026, selling an estimated $79.2K and leaving 24,990 shares worth $472K. The position accounts for ﹤0.01% of the portfolio, ranked #1355.

INTECH Investment Management first reported a position in DFTX in Q3 2024 and has held it in 7 quarters since. 247 funds tracked by Wall St. Rank hold DFTX as of Q1 2026.

  • INTECH Investment Management held 24,990 shares of Definium Therapeutics worth $472K as of Q1 2026.
  • INTECH Investment Management sold 4,665 Definium Therapeutics shares in Q1 2026, an estimated $79.2K.
  • Definium Therapeutics made up ﹤0.01% of INTECH Investment Management's portfolio in Q1 2026, its #1355 holding.
  • INTECH Investment Management first reported a position in Definium Therapeutics in Q3 2024 and has held it in 7 quarters since.
  • 247 funds tracked by Wall St. Rank held Definium Therapeutics as of Q1 2026.

Based on INTECH Investment Management's 13F filing for Q1 2026, filed 8 May 2026.